Back to Agenda
CONSIDERATIONS IN DEVELOPMENT OF COMBINATION PRODUCTS
Session Chair(s)
Manfred Maeder, PhD
Head of Device Development & Commercialization
Novartis, Switzerland
Speaker(s)
Manufacturing and Quality Aspects
Manfred Maeder, PhD
Novartis, Switzerland
Head of Device Development & Commercialization
Blake Green
Amgen, United Kingdom
Regulatory Affairs Senior Manager
Assessing Classification of Borderline Products
Shayesteh Fürst-Ladani, MBA, MS
SFL Regulatory Affairs & Scientific Communication, Switzerland
CEO
Have an account?